{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:54:03Z","timestamp":1781632443796,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Spinal malignant lesions are a common feature in multiple myeloma (MM) and often require surgical intervention. Accurate survival prediction is critical for guiding treatment decisions in these patients. While PATHFx is a widely used, machine-learning-based prognostic tool for skeletal metastases, it has not been validated for malignant bone lesions in MM so far.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the predictive performance and clinical utility of PATHFx 3.0 in a well-characterized cohort of MM patients with spinal malignant lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort of 100 MM patients with radiologically confirmed spinal malignant lesions treated between 2009 and 2024 at a tertiary care center was analyzed. 51 patients underwent surgery for the local treatment of spinal lesions, while 49 were treated with non-operative treatment regimes. Clinical data were entered into PATHFx 3.0 to generate survival estimates at 1, 3, 6, 12, 18, and 24 months. Model performance was assessed using Receiver Operating Curves (ROC) with Area under the Curve (AUC), Brier scores, calibration plots, and decision curve analysis (DCA), and compared to the actual survival in this cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PATHFx achieved good discriminatory performance at all time points, with AUC values ranging from 0.72 (1 month) to 0.79 (18 months). Calibration improved with longer prediction intervals, and Brier scores ranged from 0.09 to 0.20, with best accuracy at 3 months. DCA showed net clinical benefit for all models except the 1-month estimate. The inclusion of both surgical and non-surgical patients enhanced the generalizability of results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PATHFx 3.0 is a reliable and clinically useful tool for survival estimation in MM patients with spinal disease. Its flexible design and acceptable predictive performance support its use in multidisciplinary treatment planning, especially where traditional scoring systems fall short.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-026-04208-7","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T01:53:13Z","timestamp":1769478793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predicting survival of patients with spinal involvement in multiple myeloma using PATHFx 3.0 \u2013 a validation study of 100 patients in Germany"],"prefix":"10.1186","volume":"24","author":[{"given":"Julian","family":"Kylies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Brauneck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias M.","family":"Ballhause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Weisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Schomacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Obid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon-Gordian","family":"Leonhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Viezens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"5","key":"4208_CR1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jama.2022.0003","volume":"327","author":"AJ Cowan","year":"2022","unstructured":"Cowan AJ, Green DJ, Kwok M, et al Diagnosis and management of multiple myeloma: a review. JAMA. 2022;327(5):464\u201377. https:\/\/doi.org\/10.1001\/jama.2022.0003.","journal-title":"JAMA"},{"issue":"3","key":"4208_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.soncn.2017.05.012","volume":"33","author":"K Brigle","year":"2017","unstructured":"Brigle K, Rogers B. Pathobiology and diagnosis of multiple myeloma. Semin Oncol Nurs Aug. 2017;33(3):225\u201336. https:\/\/doi.org\/10.1016\/j.soncn.2017.05.012.","journal-title":"Semin Oncol Nurs Aug"},{"issue":"2","key":"4208_CR3","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.3171\/2016.6.FOCUS16166","volume":"41","author":"D Bakar","year":"2016","unstructured":"Bakar D, Tanenbaum JE, Phan K, et al. Decompression surgery for spinal metastases: a systematic review. Neurosurg Focus Aug. 2016;41(2):E2. https:\/\/doi.org\/10.3171\/2016.6.FOCUS16166.","journal-title":"Neurosurg Focus Aug"},{"issue":"4","key":"4208_CR4","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3109\/0284186x.2012.705437","volume":"52","author":"S Crnalic","year":"2013","unstructured":"Crnalic S, Hildingsson C, Bergh A, Widmark A, Svensson O, L\u00f6fvenberg R. Early diagnosis and treatment is crucial for neurological recovery after surgery for metastatic spinal cord compression in prostate cancer. Acta Oncol May. 2013;52(4):809\u201315. https:\/\/doi.org\/10.3109\/0284186x.2012.705437.","journal-title":"Acta Oncol May"},{"issue":"10","key":"4208_CR5","first-page":"711","volume":"59","author":"DS Bradford","year":"1976","unstructured":"Bradford DS, Thompson RC. Fractures and dislocations of the spine. Indications for surgical intervention. Minn Med Oct. 1976;59(10):711\u201320.","journal-title":"Minn Med Oct"},{"issue":"8","key":"4208_CR6","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/jso.24620","volume":"115","author":"NR Paulino Pereira","year":"2017","unstructured":"Paulino Pereira NR, McLaughlin L, Janssen SJ, et al. The SORG nomogram accurately predicts 3- and 12-months survival for operable spine metastatic disease: external validation. J Surg Oncol Jun. 2017;115(8):1019\u201327. https:\/\/doi.org\/10.1002\/jso.24620.","journal-title":"J Surg Oncol Jun"},{"issue":"18","key":"4208_CR7","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1182\/blood-2010-10-299529","volume":"5","author":"M Dimopoulos","year":"2011","unstructured":"Dimopoulos M, Kyle R, Fermand JP, et al. Consensus recommendations for standard investigative workup: report of the international myeloma workshop consensus panel 3. Blood May. 2011;5(18):4701\u20135. https:\/\/doi.org\/10.1182\/blood-2010-10-299529.","journal-title":"Blood May"},{"issue":"8","key":"4208_CR8","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1016\/s1470-2045(16)30206-6","volume":"17","author":"S Kumar","year":"2016","unstructured":"Kumar S, Paiva B, Anderson KC, et al. International myeloma working group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol Aug. 2016;17(8):e328\u201346. https:\/\/doi.org\/10.1016\/s1470-2045(16)30206-6.","journal-title":"Lancet Oncol Aug"},{"issue":"6","key":"4208_CR9","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/brs.0000000000003289","volume":"15","author":"C Carrwik","year":"2020","unstructured":"Carrwik C, Olerud C, Robinson Y. Predictive scores underestimate survival of patients with metastatic spine disease: A retrospective study of 315 patients in Sweden. Spine (Phila Pa 1976) Mar. 2020;15(6):414\u20139. https:\/\/doi.org\/10.1097\/brs.0000000000003289.","journal-title":"Spine (Phila Pa 1976) Mar"},{"issue":"11","key":"4208_CR10","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1007\/s00586-008-0763-1","volume":"17","author":"A Leithner","year":"2008","unstructured":"Leithner A, Radl R, Gruber G, et al. Predictive value of seven preoperative prognostic scoring systems for spinal metastases. Eur Spine J Nov. 2008;17(11):1488\u201395. https:\/\/doi.org\/10.1007\/s00586-008-0763-1.","journal-title":"Eur Spine J Nov"},{"issue":"3","key":"4208_CR11","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00586-015-4339-6","volume":"25","author":"C Zoccali","year":"2016","unstructured":"Zoccali C, Skoch J, Walter CM, Torabi M, Borgstrom M, Baaj AA. The Tokuhashi score: effectiveness and pitfalls. Eur Spine J Mar. 2016;25(3):673\u20138. https:\/\/doi.org\/10.1007\/s00586-015-4339-6.","journal-title":"Eur Spine J Mar"},{"issue":"4","key":"4208_CR12","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00586-016-4921-6","volume":"27","author":"A Aoude","year":"2018","unstructured":"Aoude A, Fortin M, Aldebeyan S, et al. The revised Tokuhashi score; analysis of parameters and assessment of its accuracy in determining survival in patients afflicted with spinal metastasis. Eur Spine J Apr. 2018;27(4):835\u201340. https:\/\/doi.org\/10.1007\/s00586-016-4921-6.","journal-title":"Eur Spine J Apr"},{"issue":"1","key":"4208_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3944\/aott.2012.2645","volume":"46","author":"S Papastefanou","year":"2012","unstructured":"Papastefanou S, Alpantaki K, Akra G, Katonis P. Predictive value of Tokuhashi and Tomita scores in patients with metastatic spine disease. Acta Orthop Traumatol Turc. 2012;46(1):50\u20136. https:\/\/doi.org\/10.3944\/aott.2012.2645.","journal-title":"Acta Orthop Traumatol Turc"},{"issue":"2","key":"4208_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11060-015-1794-1","volume":"123","author":"CH Lee","year":"2015","unstructured":"Lee CH, Chung CK, Jahng TA, et al. Which one is a valuable surrogate for predicting survival between Tomita and Tokuhashi scores in patients with spinal metastases? A meta-analysis for diagnostic test accuracy and individual participant data analysis. J Neurooncol Jun. 2015;123(2):267\u201375. https:\/\/doi.org\/10.1007\/s11060-015-1794-1.","journal-title":"J Neurooncol Jun"},{"issue":"3","key":"4208_CR15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1503\/cjs.012013","volume":"57","author":"A Aoude","year":"2014","unstructured":"Aoude A, Amiot LP. A comparison of the modified Tokuhashi and Tomita scores in determining prognosis for patients afflicted with spinal metastasis. Can J Surg Jun. 2014;57(3):188\u201393. https:\/\/doi.org\/10.1503\/cjs.012013.","journal-title":"Can J Surg Jun"},{"issue":"1","key":"4208_CR16","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1186\/s12885-018-5139-2","volume":"13","author":"XG Yang","year":"2018","unstructured":"Yang XG, Lun DX, Hu YC, et al. Prognostic effect of factors involved in revised Tokuhashi score system for patients with spinal metastases: a systematic review and Meta-analysis. BMC Cancer Dec. 2018;13(1):1248. https:\/\/doi.org\/10.1186\/s12885-018-5139-2.","journal-title":"BMC Cancer Dec"},{"issue":"10","key":"4208_CR17","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1002\/jor.24763","volume":"38","author":"AL Overmann","year":"2020","unstructured":"Overmann AL, Clark DM, Tsagkozis P, Wedin R, Forsberg JA. Validation of PATHFx 2.0: an open-source tool for estimating survival in patients undergoing pathologic fracture fixation. J Orthop Res Oct. 2020;38(10):2149\u201356. https:\/\/doi.org\/10.1002\/jor.24763.","journal-title":"J Orthop Res Oct"},{"key":"4208_CR18","doi-asserted-by":"publisher","first-page":"101669","DOI":"10.1016\/j.bas.2022.101669","volume":"2","author":"C Carrwik","year":"2022","unstructured":"Carrwik C, Tsagkozis P, Wedin R, Robinson Y. Predicting survival of patients with spinal metastatic disease using PathFx 3.0 - A validation study of 668 patients in Sweden. Brain Spine. 2022;2:101669. https:\/\/doi.org\/10.1016\/j.bas.2022.101669.","journal-title":"Brain Spine"},{"issue":"7","key":"4208_CR19","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.spinee.2025.01.014","volume":"25","author":"BJJ Bindels","year":"2025","unstructured":"Bindels BJJ, Kuijten RH, Groot OQ, et al. External validation of 12 existing survival prediction models for patients with spinal metastases. Spine J Jul. 2025;25(7):1347\u201359. https:\/\/doi.org\/10.1016\/j.spinee.2025.01.014.","journal-title":"Spine J Jul"},{"issue":"4","key":"4208_CR20","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1097\/corr.0000000000001081","volume":"478","author":"AB Anderson","year":"2020","unstructured":"Anderson AB, Wedin R, Fabbri N, Boland P, Healey J, Forsberg JA. External validation of PATHFx version 3.0 in patients treated surgically and nonsurgically for symptomatic skeletal metastases. Clin Orthop Relat Res Apr. 2020;478(4):808\u201318. https:\/\/doi.org\/10.1097\/corr.0000000000001081.","journal-title":"Clin Orthop Relat Res Apr"},{"key":"4208_CR21","doi-asserted-by":"publisher","first-page":"100225","DOI":"10.1016\/j.jbo.2019.100225","volume":"15","author":"C Meares","year":"2019","unstructured":"Meares C, Badran A, Dewar D. Prediction of survival after surgical management of femoral metastatic bone disease - A comparison of prognostic models. J Bone Oncol Apr. 2019;15:100225. https:\/\/doi.org\/10.1016\/j.jbo.2019.100225.","journal-title":"J Bone Oncol Apr"},{"key":"4208_CR22","doi-asserted-by":"publisher","unstructured":"Bernstein ZS, Kim EB, Raje N. Bone disease in multiple myeloma: biologic and clinical implications. Cells. 2022;27(15). https:\/\/doi.org\/10.3390\/cells11152308.","DOI":"10.3390\/cells11152308"},{"issue":"2","key":"4208_CR23","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s11899-021-00633-5","volume":"16","author":"L Bertamini","year":"2021","unstructured":"Bertamini L, D\u2019Agostino M, Gay F. MRD assessment in multiple myeloma: progress and challenges. Curr Hematol Malig Rep Apr. 2021;16(2):162\u201371. https:\/\/doi.org\/10.1007\/s11899-021-00633-5.","journal-title":"Curr Hematol Malig Rep Apr"},{"issue":"6","key":"4208_CR24","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3324\/haematol.2013.100552","volume":"99","author":"NW van de Donk","year":"2014","unstructured":"van de Donk NW, Palumbo A, Johnsen HE, et al. The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European myeloma network. Haematologica Jun. 2014;99(6):984\u201396. https:\/\/doi.org\/10.3324\/haematol.2013.100552.","journal-title":"Haematologica Jun"},{"issue":"3","key":"4208_CR25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/leu.2008.336","volume":"23","author":"GD Roodman","year":"2009","unstructured":"Roodman GD. Pathogenesis of myeloma bone disease. Leukemia Mar. 2009;23(3):435\u201341. https:\/\/doi.org\/10.1038\/leu.2008.336.","journal-title":"Leukemia Mar"},{"issue":"2","key":"4208_CR26","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.3390\/curroncol30020179","volume":"15","author":"P Bhatt","year":"2023","unstructured":"Bhatt P, Kloock C, Comenzo R. Relapsed\/Refractory multiple myeloma: A review of available therapies and clinical scenarios encountered in myeloma relapse. Curr Oncol Feb. 2023;15(2):2322\u201347. https:\/\/doi.org\/10.3390\/curroncol30020179.","journal-title":"Curr Oncol Feb"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04208-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04208-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04208-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:10:14Z","timestamp":1781629814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04208-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4208"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04208-7","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. Due to its retrospective and anonymous design, the requirement for informed consent was waived by the Ethics Committee of the Hamburg Medical Association, ID: 2025-300576-WF.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to publish this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}